Therapeutic Asset Ratings
183 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ponatinib
Acute Lymphoblastic Leukemia
University of Alberta
P2/3
B
(60)
Treosulfan
Acute Lymphoblastic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P2/3
B
(60)
Romidepsin
Acute Lymphoblastic Leukemia
Sawa Ito, MD
P3
B
(59)
ABATACEPT RECOMBINANT
Acute Lymphoblastic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P3
B
(58)
Nelarabine
Acute Lymphoblastic Leukemia
Emory University
P3
B
(58)
VITAMIN D
Acute Lymphoblastic Leukemia
St. Petersburg State Pavlov Medical University
P3
B
(58)
Azacitidine
Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
P2
B
(58)
Benadryl
Acute Lymphoblastic Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
P2
B
(58)
Cart-19 And 20 Cells
Acute Lymphoblastic Leukemia
University of Sao Paulo
P2/3
B
(58)
Cladribine
Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
P2/3
B
(58)
Ibrutinib
Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
P2
B
(57)
L-Ofloxacin
Acute Lymphoblastic Leukemia
Gadjah Mada University
P4
B
(56)
SIMVASTATIN
Acute Lymphoblastic Leukemia
Hospital General de Mexico
P4
B
(56)
URSODEOXYCHOLIC ACID
Acute Lymphoblastic Leukemia
Ain Shams University
P4
B
(56)
Olverembatinib
Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
P3
B
(56)
cd22 car-transduced t cells
Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P2
B
(56)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
Acute Lymphoblastic Leukemia
City of Hope Medical Center
P2
B
(56)
Revumenib
Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
P2
B
(56)
Vorinostat
Acute Lymphoblastic Leukemia
Tanja Andrea Gruber
P2/3
B
(56)
ceftazidime
Acute Lymphoblastic Leukemia
Gadjah Mada University
P4
CCC
(54)
Ciprofloxacin
Acute Lymphoblastic Leukemia
Gadjah Mada University
P4
CCC
(54)
Dexrazoxane
Acute Lymphoblastic Leukemia
Andrew E. Place, MD
P3
CCC
(54)
Inotuzumab
Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital
P3
CCC
(54)
PEGFILGRASTIM
Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
P2
CCC
(54)
Everolimus
Acute Lymphoblastic Leukemia
OHSU Knight Cancer Institute
P1/2
CCC
(54)
Showing 51 to 75 of 183 assets
Previous
Page 3 of 8
Next